HomeCompareMAHMF vs PFE

MAHMF vs PFE: Dividend Comparison 2026

MAHMF yields 0.87% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MAHMF wins by $2.82M in total portfolio value
10 years
MAHMF
MAHMF
● Live price
0.87%
Share price
$33.50
Annual div
$0.29
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2.87M
Annual income
$2,346,203.74
Full MAHMF calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — MAHMF vs PFE

📍 MAHMF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMAHMFPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MAHMF + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MAHMF pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MAHMF
Annual income on $10K today (after 15% tax)
$73.58/yr
After 10yr DRIP, annual income (after tax)
$1,994,273.18/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, MAHMF beats the other by $1,971,953.28/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MAHMF + PFE for your $10,000?

MAHMF: 50%PFE: 50%
100% PFE50/50100% MAHMF
Portfolio after 10yr
$1.46M
Annual income
$1,186,231.23/yr
Blended yield
81.35%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

MAHMF
No analyst data
Altman Z
2.2
Piotroski
2/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MAHMF buys
0
PFE buys
0
No recent congressional trades found for MAHMF or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMAHMFPFE
Forward yield0.87%6.13%
Annual dividend / share$0.29$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%13.2%
Portfolio after 10y$2.87M$49.6K
Annual income after 10y$2,346,203.74$26,258.71
Total dividends collected$2.80M$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: MAHMF vs PFE ($10,000, DRIP)

YearMAHMF PortfolioMAHMF Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$10,873$173.13$9,153$693.39+$1.7KMAHMF
2$11,986$351.87$8,593$849.25+$3.4KMAHMF
3$13,550$725.03$8,336$1,066.78+$5.2KMAHMF
4$16,031$1,532.03$8,437$1,384.80+$7.6KMAHMF
5$20,541$3,387.83$9,013$1,875.40+$11.5KMAHMF
6$30,092$8,113.90$10,306$2,680.72+$19.8KMAHMF
7$54,418$22,218.67$12,820$4,101.38+$41.6KMAHMF
8$133,328$75,101.04$17,673$6,826.70+$115.7KMAHMF
9$486,594$343,932.99$27,543$12,591.86+$459.1KMAHMF
10$2,866,859$2,346,203.74$49,560$26,258.71+$2.82MMAHMF

MAHMF vs PFE: Complete Analysis 2026

MAHMFStock

Mahindra & Mahindra Limited provides mobility products and farm solutions in India and internationally. The company operates through Automotive, Farm Equipment, Financial Services, Hospitality, Real Estate, and Others segments. It offers parts and assemblies for aerospace and defense sectors; passenger and commercial vehicles, trucks, buses, vans, cars, utility vehicles, and electric vehicles; watercrafts; motorcycles, scooters, and mopeds; construction equipment, such as backhoe loaders under the Mahindra EarthMaster brand; and road construction equipment comprising motor graders under the Mahindra RoadMaster brand. The company also provides land and naval systems, defense electronics, and security consulting services for defense industry; pre-owned car and car services; and farm equipment. In addition, it operates M2All, an e-commerce platform for various portfolio of products; approximately 100 resorts; and solar PV projects. Further, the company offers financial services comprising retail and other loans, SME finance, housing finance, mutual funds, and life and non-life insurance broking services, as well as vehicle and equipment financing; logistics services; information security and risk management, engineering consulting, and business process management consulting services; information technology services; and power backup solutions, such as diesel and gas generators. Additionally, it engages in the development, management, and operation of commercial complexes; sale of timeshare and vacation ownership; and making, processing, and trading of steel for automotive, non-automotive, and power industries. The company was incorporated in 1945 and is based in Mumbai, India.

Full MAHMF Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this MAHMF vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MAHMF vs SCHDMAHMF vs JEPIMAHMF vs OMAHMF vs KOMAHMF vs MAINMAHMF vs JNJMAHMF vs MRKMAHMF vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.